Protein tyrosine phosphatase non-receptor type 22
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
(Redirected from PTPN22)
 | This article is a stub. |
Protein Tyrosine Phosphatase Non-Receptor Type 22 or PTPN22.[1]
Function[edit | edit source]
ME/CFS[edit | edit source]
Notable studies[edit | edit source]
- 2022, Genetic association study in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) identifies several potential risk loci[2] - (Full text)
- 2020, Autoimmunity-Related Risk Variants in PTPN22 and CTLA4 Are Associated With ME/CFS With Infectious Onset[3] - (Full text)
See also[edit | edit source]
- Cytotoxic T-lymphocyte associated protein 4 (CTLA4)
- Immunoglobulin G (IgG)
- Immunoadsorption
- Autoimmune disease
- Genetics of chronic fatigue syndrome
Learn more[edit | edit source]
- PTPN22 Gene - Gene cards
References[edit | edit source]
- ↑ "PTPN22 Gene". Gene cards. Retrieved March 31, 2022.
- ↑ Hajdarevic, Riad; Lande, Asgeir; Mehlsen, Jesper; Rydland, Anne; Sosa, Daisy D.; Strand, Elin B.; Mella, Olav; Pociot, Flemming; Fluge, Øystein; Lie, Benedicte A.; Viken, Marte K. (May 1, 2022). "Genetic association study in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) identifies several potential risk loci". Brain, Behavior, and Immunity. 102: 362–369. doi:10.1016/j.bbi.2022.03.010. ISSN 0889-1591.
- ↑ Steiner, Sophie; Becker, Sonya C.; Hartwig, Jelka; Sotzny, Franziska; Lorenz, Sebastian; Bauer, Sandra; Löbel, Madlen; Stittrich, Anna B.; Grabowski, Patricia; Scheibenbogen, Carmen (2020). "Autoimmunity-Related Risk Variants in PTPN22 and CTLA4 Are Associated With ME/CFS With Infectious Onset". Frontiers in Immunology. 11: 578. doi:10.3389/fimmu.2020.00578. ISSN 1664-3224.
